L3VLUP
ProSign in

AUPH · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

AUPHJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • AUPH
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterAUPHJNJ
Q3 20203 holders, $57m30 holders, $26.2bn
Q4 20202 holders, $39m32 holders, $26.6bn
Q1 20211 holders, $10m31 holders, $25.3bn
Q2 20211 holders, $8.2m37 holders, $25.6bn
Q3 20212 holders, $19m40 holders, $24.1bn
Q4 20212 holders, $24m33 holders, $25.2bn
Q1 20221 holders, $866k35 holders, $28.2bn
Q2 20221 holders, $1.7m33 holders, $26.9bn
Q3 20221 holders, $2.2m36 holders, $25.4bn
Q4 20221 holders, $5.3m35 holders, $27.6bn
Q1 20233 holders, $34m42 holders, $24.5bn
Q2 20231 holders, $4.8m38 holders, $25.0bn
Q3 20231 holders, $3.9m37 holders, $18.9bn
Q4 20231 holders, $5.8m31 holders, $19.0bn
Q1 20241 holders, $2.5m32 holders, $19.7bn
Q2 20242 holders, $4.5m35 holders, $20.4bn
Q3 20242 holders, $5.9m28 holders, $22.3bn
Q4 20242 holders, $10m37 holders, $20.4bn
Q1 20251 holders, $2.5m32 holders, $20.5bn
Q2 20251 holders, $2.8m31 holders, $18.4bn
Q3 20251 holders, $2.9m32 holders, $23.7bn
Q4 20254 holders, $104m29 holders, $27.8bn
Q1 20263 holders, $54m34 holders, $35.6bn
Q2 20262 holders, $63m33 holders, $39.1bn
AUPH

Aurinia Pharmaceuticals Inc

Holders
2
Reported value
$5.9m
Buyers
1
Sellers
1

Breadth 0 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
JNJ

Johnson & Johnson

Holders
28
Reported value
$22.3bn
Buyers
13
Sellers
16

Breadth -3 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q3 2024

Among the 29 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only AUPH (1)

PDT Partners LLC

Only JNJ (27)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Dodge & Cox, Eisler Capital Management Ltd, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, Marshall Wace LLP, MFS Investment Management, Neuberger Berman Group LLC, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, and 2 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →